ARS Pharmaceuticals (SPRY) EPS (Basic) (2020 - 2026)
ARS Pharmaceuticals' (SPRY) quarterly EPS (Basic) came in at -$0.61 in Q1 2026, down 74.29% year-on-year from -$2.37 in Q1 2025, and down 45.24% quarter-over-quarter from -$0.42 in Q4 2025.
ARS Pharmaceuticals (SPRY) EPS (Basic) (2020 - 2026) Analysis & Trends
ARS Pharmaceuticals has disclosed EPS (Basic) across 7 years of filings, most recently posting -$0.61 for Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.61, down 74.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.01 (down 1082.35% YoY), and the FY2025 annual result was -$1.74, down 2275.0% from the prior year.
- EPS (Basic) came in at -$0.61 for Q1 2026 at ARS Pharmaceuticals, down from -$0.42 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.89 in Q4 2022 to a low of -$0.7 in Q1 2022.
- The 5-year median for EPS (Basic) is -$0.2 (2024), against an average of -$0.22.
- Across the five-year window, EPS (Basic) soared 828.57% in 2024 and plunged 253.85% in 2025, its largest moves.
- ARS Pharmaceuticals' EPS (Basic) stood at $0.89 in 2022, then slumped by 107.87% to -$0.07 in 2023, then jumped by 828.57% to $0.51 in 2024, then tumbled by 182.35% to -$0.42 in 2025, then sank by 45.24% to -$0.61 in 2026.
- The last three EPS (Basic) figures came in at -$0.61 (Q1 2026), -$0.42 (Q4 2025), and -$0.52 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | ARS Pharmaceuticals | 954.24 Mn | 753.27 Mn | - | -0.61 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.61 |
| Dec 31, 2025 | -0.42 |
| Sep 30, 2025 | -0.52 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -0.35 |
| Dec 31, 2024 | 0.51 |
| Sep 30, 2024 | -0.20 |
| Jun 30, 2024 | -0.13 |
| Mar 31, 2024 | -0.11 |
| Dec 31, 2023 | -0.07 |
| Sep 30, 2023 | -0.16 |
| Jun 30, 2023 | -0.18 |
| Mar 31, 2023 | -0.20 |
| Dec 31, 2022 | 0.89 |
| Sep 30, 2022 | -0.50 |
| Jun 30, 2022 | -0.55 |
| Mar 31, 2022 | -0.70 |
| Dec 31, 2021 | 1.19 |
| Sep 30, 2021 | -0.65 |
| Jun 30, 2021 | -0.70 |